192 related articles for article (PubMed ID: 19909255)
41. DDAH-2 alleviates contrast medium iopromide-induced acute kidney injury through nitric oxide synthase.
Lin HH; Lee TS; Lin SJ; Yeh YC; Lu TM; Hsu CP
Clin Sci (Lond); 2019 Dec; 133(23):2361-2378. PubMed ID: 31763675
[TBL] [Abstract][Full Text] [Related]
42. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW
Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158
[TBL] [Abstract][Full Text] [Related]
43. The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes.
Spoto B; Parlongo RM; Parlongo G; Sgro' E; Zoccali C
J Nephrol; 2007; 20(5):554-9. PubMed ID: 17918140
[TBL] [Abstract][Full Text] [Related]
44. Involvement of the endothelial DDAH/ADMA pathway in nitroglycerin tolerance: the role of ALDH-2.
Zhang GG; Shi RZ; Jiang DJ; Chen YR; Jia-Chen ; Tang ZY; Bai YP; Xiao HB; Li YJ
Life Sci; 2008 Mar; 82(13-14):699-707. PubMed ID: 18289604
[TBL] [Abstract][Full Text] [Related]
45. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence.
Dayoub H; Achan V; Adimoolam S; Jacobi J; Stuehlinger MC; Wang BY; Tsao PS; Kimoto M; Vallance P; Patterson AJ; Cooke JP
Circulation; 2003 Dec; 108(24):3042-7. PubMed ID: 14638548
[TBL] [Abstract][Full Text] [Related]
46. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine.
Yin QF; Fu SH; He P; Xiong Y
Atherosclerosis; 2007 Jan; 190(1):53-61. PubMed ID: 16533509
[TBL] [Abstract][Full Text] [Related]
47. ADMA: its role in vascular disease.
Cooke JP
Vasc Med; 2005 Jul; 10 Suppl 1():S11-7. PubMed ID: 16444864
[TBL] [Abstract][Full Text] [Related]
48. Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.
De Gennaro Colonna V; Bianchi M; Pascale V; Ferrario P; Morelli F; Pascale W; Tomasoni L; Turiel M
Med Sci Monit; 2009 Apr; 15(4):RA91-101. PubMed ID: 19333216
[TBL] [Abstract][Full Text] [Related]
49. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
McCarty MF
Med Hypotheses; 2004; 63(4):699-708. PubMed ID: 15325021
[TBL] [Abstract][Full Text] [Related]
50. Asymmetric dimethyl-arginine metabolism in a murine model of cigarette smoke-mediated lung inflammation.
Staab EB; Weigel J; Xiao F; Madayiputhiya N; Wyatt TA; Wells SM
J Immunotoxicol; 2015; 12(3):273-82. PubMed ID: 25913572
[TBL] [Abstract][Full Text] [Related]
51. A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.
Buijs N; Oosterink JE; Jessup M; Schierbeek H; Stolz DB; Houdijk AP; Geller DA; van Leeuwen PA
Angiogenesis; 2017 Nov; 20(4):557-565. PubMed ID: 28741166
[TBL] [Abstract][Full Text] [Related]
52. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
53. Endogenous inhibitors of nitric oxide and preeclampsia: a review.
Slaghekke F; Dekker G; Jeffries B
J Matern Fetal Neonatal Med; 2006 Aug; 19(8):447-52. PubMed ID: 16966108
[TBL] [Abstract][Full Text] [Related]
54. The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.
Visser M; Paulus WJ; Vermeulen MA; Richir MC; Davids M; Wisselink W; de Mol BA; van Leeuwen PA
Eur J Heart Fail; 2010 Dec; 12(12):1274-81. PubMed ID: 20923854
[TBL] [Abstract][Full Text] [Related]
55. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
56. Protective effect of neferine on endothelial cell nitric oxide production induced by lysophosphatidylcholine: the role of the DDAH-ADMA pathway.
Peng ZY; Zhang SD; Liu S; He BM
Can J Physiol Pharmacol; 2011 Apr; 89(4):289-94. PubMed ID: 21526974
[TBL] [Abstract][Full Text] [Related]
57. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase.
Achan V; Broadhead M; Malaki M; Whitley G; Leiper J; MacAllister R; Vallance P
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1455-9. PubMed ID: 12805079
[TBL] [Abstract][Full Text] [Related]
58. Nitric oxide synthase derangements and hypertension in kidney disease.
Baylis C
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):1-6. PubMed ID: 22048724
[TBL] [Abstract][Full Text] [Related]
59. Endogenous nitric-oxide synthase inhibitor ADMA after acute brain injury.
Jung CS; Wispel C; Zweckberger K; Beynon C; Hertle D; Sakowitz OW; Unterberg AW
Int J Mol Sci; 2014 Mar; 15(3):4088-103. PubMed ID: 24663083
[TBL] [Abstract][Full Text] [Related]
60. All-trans retinoic acid inhibits cobalt chloride-induced apoptosis in PC12 cells: role of the dimethylarginine dimethylaminohydrolase/asymmetric dimethylarginine pathway.
Wang S; Hu CP; Jiang DJ; Peng J; Zhou Z; Yuan Q; Nie SD; Jiang JL; Li YJ; Huang KL
J Neurosci Res; 2009 Jun; 87(8):1938-46. PubMed ID: 19156866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
